Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1937056 | Biochemical and Biophysical Research Communications | 2007 | 6 Pages |
Abstract
Apolipoprotein E (ApoE) plays an important role in the development of atherosclerosis. Previous studies provide evidence for an atheroprotective role of ApoE in mouse models on the ApoE deficient (ApoEâ/â) background. However, it is not clear whether this is also true on the LDL-receptor deficient (LDLRâ/â) background. Transgenic mice carrying hApoE coding sequences in a chicken lysozyme expression cassette were generated. Transgene expression was directed into macrophages, expressing low levels of hApoE. Expression of the hApoE transgene was not sufficient to correct hypercholesterolemia. However, lesion area at the brachiocephalic artery (BCA) was significantly reduced (â72%) in female hApoE transgenic mice on the LDLRâ/â background. This was associated with increased cholesterol efflux in macrophages of transgenic animals on the ApoEâ/â background. We conclude that over-expression of ApoE in macrophages might be useful as a therapeutic principle for the prevention of atherosclerosis.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Carsten Tennert, Daniel Teupser, Marc A. Mueller, Wolfgang Wilfert, Ingrid Renner-Müller, Olga Stein, Yechezkiel Stein, Albrecht E. Sippel, Eckhard Wolf, Joachim Thiery,